LYMPHOMA COALITION
is a worldwide network of patient organisations with a full or partials focus on providing support to those affected by lymphoma, including chronic lymphocytic leukemia.
Find a Member Organisation Near You
Learn more about the findings from the 2024 Global Patient Survey (GPS) on Lymphoma & CLL
View ReportSearch The Resource Library
Browse information on lymphoma diagnosis, treatment & survivorship
📣 The updated Lymphoma Patient Charter is now LIVE!
The Lymphoma Patient Charter offers a structured summary of the key priorities expressed by people with lived experience with lymphoma, outlining patient-centred principles in lymphoma care.
Developed with input from people with lived experience and patient organisations around the world, this Charter outlines key principles for patient-centred lymphoma care.
From strengthening global advocacy to integrating holistic support and promoting shared decision-making, the Charter is a powerful tool to guide research, policy, and care planning.
🔗 Explore the Charter and access supporting resources now at: lymphomacoalition.org/lymphoma-patient-charter/
#patientcentredcare #lymsm #healthequity #patientvoice ... See MoreSee Less
🤔 Wondering what CLL drug categories look like today? Find out about different approaches and why your perspective matters.
Share your experience by taking our short survey.
🎯 openhealth.questionpro.com/CLL-treatment-preferences-survey
#clltreatment #CLLAwareness #clladvocacy #SurveyForChange ... See MoreSee Less
📈 We’re seeing incredible participation—thank you! But we still need more voices to ensure the data reflects the whole CLL community.
If you haven’t taken the survey yet, there’s still time.
Let’s keep the momentum going.
🔗 openhealth.questionpro.com/CLL-treatment-preferences-survey
#CLLsurvey #TogetherForChange #CLLawareness #YourStoryMatters #poweredbyAZ ... See MoreSee Less
Lorna Warwick, CEO of Lymphoma Coalition, contributed to a publication in HemaSphere titled "European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological Malignancies."
The article outlines standards aimed at improving care for people with blood cancers across Europe and highlights the importance of coordinated, patient-centred care.
Defining these essential requirements is key to reducing disparities in access and ensuring consistent, high-quality care for all patients, regardless of where they live.
📖 Read it here: onlinelibrary.wiley.com/doi/10.1002/hem3.70108
#lymsm #Lymphoma #PatientAdvocacy #CancerCare #Hematology ... See MoreSee Less
⏳ Still wondering why you should take the CLL Survey?
Here are 3 reasons why:
✅ Your input is unique
✅ You can shape future treatments
✅ It only takes a few minutes
Every response counts!
🔗 openhealth.questionpro.com/a/TakeSurvey?tt=CCwhLinnRB8ECHrPeIW9eQ%3D%3D
#cllsurvey #speakupforscience #oncologycare #PatientVoicesMatter #poweredbyAZ ... See MoreSee Less
Despite the opportunity for cure CAR T-cell therapy provides, only approximately 2 out of 10 people in the US with some advanced #BloodCancers receive access. The CAR T Vision is launching with the aim to double the proportion of eligible patients treated with CAR T-cell therapy by 2030. It’s going to take all of us working together to make the CAR T Vision a reality. Learn more, read the new roadmap report and join the growing coalition at: bit.ly/3GXqHDE #CARTVision ... See MoreSee Less